Overview

Special Drug Use Surveillance on Long-term Use of Sodium Risedronate Tablets (Benet 75 mg Tablets) (12-month Treatment Survey)

Status:
Completed
Trial end date:
2016-04-30
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety and efficacy of sodium risedronate tablets (Benet 75 mg Tablets) in osteoporosis patients in daily medical practice, as well as to examine "the status of treatment compliance" - i.e., whether sodium risedronate tablets are taken properly in accordance with the prescribed once-monthly regimen
Details
Lead Sponsor:
Takeda
Treatments:
Etidronic Acid
Risedronate Sodium
Risedronic Acid